Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Current
    • Residents & Fellows
    • Without Borders
    • Practice Buzz
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Current
    • Residents & Fellows
    • Without Borders
    • Practice Buzz
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub

Share

March 2018; 5 (2) Correction

Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod

First published January 31, 2018, DOI: https://doi.org/10.1212/NXI.0000000000000445
Full PDF
Citation
Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod
Neurol Neuroimmunol Neuroinflamm Mar 2018, 5 (2) e445; DOI: 10.1212/NXI.0000000000000445

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
327

Share

See original article:

  • Reverse of Errata - March 01, 2018
  • Article
  • Info & Disclosures
Loading

Article Information

vol. 5 no. 2 e445
DOI: 
https://doi.org/10.1212/NXI.0000000000000445
PubMed: 
29417951

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • First Published January 31, 2018.

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    View Full Text

    Article usage

    Article usage: January 2018 to April 2022

    AbstractFullPdfSource
    Jan 2018080Highwire
    Feb 2018028041Highwire
    Mar 2018023020Highwire
    Apr 201805814Highwire
    Apr 2018121316pmc
    May 20180503Highwire
    Jun 20180525Highwire
    Jun 2018345pmc
    Jul 20180434Highwire
    Aug 20181462Highwire
    Aug 20183910pmc
    Sep 20180678Highwire
    Oct 20180433Highwire
    Nov 20180260Highwire
    Dec 20180192Highwire
    Jan 20190101Highwire
    Feb 201912742Highwire
    Mar 201942913Highwire
    Apr 2019175Highwire
    May 20192106Highwire
    Jun 2019176Highwire
    Jul 20191209Highwire
    Aug 20193199Highwire
    Sep 2019135Highwire
    Oct 20191161Highwire
    Nov 2019065Highwire
    Dec 2019055Highwire
    Jan 2020053Highwire
    Feb 2020074Highwire
    Mar 2020042Highwire
    Apr 2020022Highwire
    May 2020072Highwire
    Jun 2020061Highwire
    Jul 2020092Highwire
    Aug 2020055Highwire
    Sep 20200135Highwire
    Oct 20201113Highwire
    Nov 20200147Highwire
    Dec 20201101Highwire
    Jan 2021146Highwire
    Feb 2021014Highwire
    Mar 2021043Highwire
    Apr 2021053Highwire
    May 2021155Highwire
    Jun 2021063Highwire
    Jul 2021144Highwire
    Aug 2021004Highwire
    Sep 2021035Highwire
    Oct 202111114Highwire
    Nov 20210516Highwire
    Dec 20210117Highwire
    Jan 2022043Highwire
    Feb 2022032Highwire
    Mar 2022196Highwire
    Apr 2022025Highwire

    Letters: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    If you are uploading a letter concerning an article:
    You must have updated your disclosures within six months: http://submit.neurology.org

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    • Article
      • Reference
    • Info & Disclosures

    Related Articles

    • Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod

    Alert Me

    • Alert me when eletters are published
    Advertisement
    Neurology - Neuroimmunology Neuroinflammation: 9 (4)

    Articles

    • Articles
    • Issues
    • Popular Articles

    About

    • About the Journals
    • Ethics Policies
    • Editors & Editorial Board
    • Contact Us
    • Advertise

    Submit

    • Author Center
    • Submit a Manuscript
    • Information for Reviewers
    • AAN Guidelines
    • Permissions

    Subscribers

    • Subscribe
    • Sign up for eAlerts
    • RSS Feed
    Site Logo
    • Visit neurology Template on Facebook
    • Follow neurology Template on Twitter
    • Visit Neurology on YouTube
    • Neurology
    • Neurology: Clinical Practice
    • Neurology: Genetics
    • Neurology: Neuroimmunology & Neuroinflammation
    • Neurology: Education
    • AAN.com
    • AANnews
    • Continuum
    • Brain & Life
    • Neurology Today

    Wolters Kluwer Logo

    Neurology: Neuroimmunology & Neuroinflammation
    Online ISSN: 2332-7812

    © 2022 American Academy of Neurology

    • Privacy Policy
    • Feedback
    • Advertise